Eucomed approves procedural framework for code of ethics in the EU
This article was originally published in RAJ Devices
European medical technology industry association Eucomed has approved a procedural framework for ensuring that companies comply with its code of ethics relating to interactions with healthcare providers1,2.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.